Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT05628974
- Status
- Recruiting
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Study Details
This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.
Key Dates
- Start date
- May 1, 2020
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2030
- Completion
- Jun 30, 2031
Study Design
- Enrollment
- 400 participants (estimated)
Primary Outcome Measure
To collect blood samples [ Time Frame: 10 years ]
Central Contacts
- Scott Cameron, MD, PhD216-444-1680
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | Rohan Bhandari, MD (SUB_INVESTIGATOR) Teresa Wu, MD (SUB_INVESTIGATOR) Morayma Reyes Gil, MD (SUB_INVESTIGATOR) |
Find similar trials in Cleveland, OH
By research site
Related Studies
- Eccentric Muscle Training, Stimulation, and Biomarkers in SCIRecruiting · Ohio State University · Columbus, Ohio
- Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral SuspensionPHASE1 · Not Yet Recruiting · Quivive Pharma, Inc. · Cleveland, Ohio
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).PHASE1 · Recruiting · Merck Sharp & Dohme LLC · Glendale, California
- Swallowing in OSA & CPAP IntoleranceEnrolling By Invitation · Denise Dewald · Cleveland, Ohio